These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23197161)

  • 21. Hypertrophic Cardiomyopathy from A to Z: Genetics, Pathophysiology, Imaging, and Management.
    Baxi AJ; Restrepo CS; Vargas D; Marmol-Velez A; Ocazionez D; Murillo H
    Radiographics; 2016; 36(2):335-54. PubMed ID: 26963450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.
    Nagueh SF; McFalls J; Meyer D; Hill R; Zoghbi WA; Tam JW; Quiñones MA; Roberts R; Marian AJ
    Circulation; 2003 Jul; 108(4):395-8. PubMed ID: 12860897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family screening in hypertrophic cardiomyopathy is underperformed, but can be improved by a specialised clinic.
    Olaussen A; Beale A; Macciocca I; Ellims AH
    Intern Med J; 2014 Jul; 44(7):665-70. PubMed ID: 24766218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.
    Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D
    Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
    Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
    J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity.
    de Feria AE; Kott AE; Becker JR
    Open Heart; 2021 Feb; 8(1):. PubMed ID: 33637569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy.
    Ingles J; McGaughran J; Scuffham PA; Atherton J; Semsarian C
    Heart; 2012 Apr; 98(8):625-30. PubMed ID: 22128210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death.
    Konno T; Shimizu M; Ino H; Fujino N; Uchiyama K; Mabuchi T; Sakata K; Kaneda T; Fujita T; Masuta E; Mabuchi H
    Clin Sci (Lond); 2006 Jan; 110(1):125-31. PubMed ID: 16181148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights Into Hypertrophic Cardiomyopathy Evaluation Through Follow-up of a Founder Pathogenic Variant.
    Lorca R; Gómez J; Martín M; Cabanillas R; Calvo J; León V; Pascual I; Morís C; Coto E; R Reguero JJ
    Rev Esp Cardiol (Engl Ed); 2019 Feb; 72(2):138-144. PubMed ID: 29631964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
    Olivotto I; Girolami F; Sciagrà R; Ackerman MJ; Sotgia B; Bos JM; Nistri S; Sgalambro A; Grifoni C; Torricelli F; Camici PG; Cecchi F
    J Am Coll Cardiol; 2011 Aug; 58(8):839-48. PubMed ID: 21835320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene mutations in apical hypertrophic cardiomyopathy.
    Arad M; Penas-Lado M; Monserrat L; Maron BJ; Sherrid M; Ho CY; Barr S; Karim A; Olson TM; Kamisago M; Seidman JG; Seidman CE
    Circulation; 2005 Nov; 112(18):2805-11. PubMed ID: 16267253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.
    Page SP; Kounas S; Syrris P; Christiansen M; Frank-Hansen R; Andersen PS; Elliott PM; McKenna WJ
    Circ Cardiovasc Genet; 2012 Apr; 5(2):156-66. PubMed ID: 22267749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
    van der Werf C; Nederend I; Hofman N; van Geloven N; Ebink C; Frohn-Mulder IM; Alings AM; Bosker HA; Bracke FA; van den Heuvel F; Waalewijn RA; Bikker H; van Tintelen JP; Bhuiyan ZA; van den Berg MP; Wilde AA
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):748-56. PubMed ID: 22787013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
    Keren A; Syrris P; McKenna WJ
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects.
    Konno T; Shimizu M; Ino H; Fujino N; Hayashi K; Uchiyama K; Kaneda T; Inoue M; Masuda E; Mabuchi H
    J Intern Med; 2005 Sep; 258(3):216-24. PubMed ID: 16115294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic spectrum of the first Belgian
    Boen HM; Alaerts M; Van Laer L; Saenen JB; Goovaerts I; Bastianen J; Koopman P; Vanduynhoven P; De Vuyst E; Rosseel M; Heidbuchel H; Van Craenenbroeck EM; Loeys B
    Front Genet; 2024; 15():1392527. PubMed ID: 38836037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.